Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors (Q36490318)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors
scientific article

    Statements

    Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors (English)
    S J Wong
    T Karrison
    D N Hayes
    M S Kies
    K J Cullen
    T Tanvetyanon
    A Argiris
    N Takebe
    N F Saba
    F P Worden
    J Gilbert
    H J Lenz
    A R A Razak
    J D Roberts
    E E W Cohen
    23 November 2015
    318-323

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit